HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-DEC-14 4RWJ TITLE CRYSTAL STRUCTURE OF FGFR1 (C488A, C584S) IN COMPLEX WITH AZD4547 (N- TITLE 2 {3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5- TITLE 3 DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C- COMPND 7 FGR; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BFGFR, CEK, FGFBR, FGFR1, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS RECEPTOR TYROSINE KINASE, KINASE, PROTO-ONCOGENE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.D.SOHL,K.S.ANDERSON REVDAT 4 20-SEP-23 4RWJ 1 REMARK SEQADV REVDAT 3 22-NOV-17 4RWJ 1 REMARK REVDAT 2 27-MAY-15 4RWJ 1 JRNL REVDAT 1 22-APR-15 4RWJ 0 JRNL AUTH C.D.SOHL,M.R.RYAN,B.LUO,K.M.FREY,K.S.ANDERSON JRNL TITL ILLUMINATING THE MOLECULAR MECHANISMS OF TYROSINE KINASE JRNL TITL 2 INHIBITOR RESISTANCE FOR THE FGFR1 GATEKEEPER MUTATION: THE JRNL TITL 3 ACHILLES' HEEL OF TARGETED THERAPY. JRNL REF ACS CHEM.BIOL. V. 10 1319 2015 JRNL REFN ISSN 1554-8929 JRNL PMID 25686244 JRNL DOI 10.1021/ACSCHEMBIO.5B00014 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 23596 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.450 REMARK 3 FREE R VALUE TEST SET COUNT : 1993 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.2226 - 5.9933 1.00 1633 151 0.1748 0.2073 REMARK 3 2 5.9933 - 4.7595 1.00 1581 145 0.1774 0.2177 REMARK 3 3 4.7595 - 4.1586 1.00 1543 142 0.1581 0.1848 REMARK 3 4 4.1586 - 3.7787 0.99 1564 140 0.1772 0.2521 REMARK 3 5 3.7787 - 3.5080 0.99 1546 149 0.2053 0.2081 REMARK 3 6 3.5080 - 3.3013 0.99 1544 140 0.2199 0.2745 REMARK 3 7 3.3013 - 3.1360 0.99 1542 142 0.2401 0.3125 REMARK 3 8 3.1360 - 2.9995 0.99 1532 142 0.2315 0.3179 REMARK 3 9 2.9995 - 2.8841 0.99 1521 142 0.2296 0.3053 REMARK 3 10 2.8841 - 2.7846 0.99 1508 140 0.2320 0.3013 REMARK 3 11 2.7846 - 2.6976 0.99 1532 148 0.2196 0.2690 REMARK 3 12 2.6976 - 2.6205 0.99 1526 138 0.2320 0.3150 REMARK 3 13 2.6205 - 2.5515 0.98 1526 140 0.2329 0.3225 REMARK 3 14 2.5515 - 2.4892 0.97 1505 134 0.2203 0.2618 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.86 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4710 REMARK 3 ANGLE : 0.652 6400 REMARK 3 CHIRALITY : 0.026 709 REMARK 3 PLANARITY : 0.003 824 REMARK 3 DIHEDRAL : 11.425 1724 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND SEGID REMARK 3 SELECTION : CHAIN B AND SEGID REMARK 3 ATOM PAIRS NUMBER : 2496 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RWJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000087883. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : CRYOGENICALLY COOLED DOUBLE REMARK 200 CRYSTAL MONOCHROMETER WITH REMARK 200 HORIZONTAL FOCUSING SAGITTAL REMARK 200 BEND SECOND MONO CRYSTAL WITH 4: REMARK 200 1 MAGNIFICATION RATIO AND REMARK 200 VERTICALLY FOCUSING MIRROR. REMARK 200 OPTICS : MONOCHROMETER REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23609 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.489 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 23.3970 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.34200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 4RWI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CACODYLATE PH 6.4, 22% REMARK 280 PEG 8000, 0.2 M AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 105.83700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.07400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 105.83700 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.07400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 449 REMARK 465 GLY A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 HIS A 455 REMARK 465 HIS A 456 REMARK 465 THR A 658 REMARK 465 GLU A 765 REMARK 465 MET B 449 REMARK 465 GLY B 450 REMARK 465 HIS B 451 REMARK 465 HIS B 452 REMARK 465 HIS B 453 REMARK 465 HIS B 454 REMARK 465 HIS B 455 REMARK 465 HIS B 456 REMARK 465 MET B 457 REMARK 465 ALA B 458 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASP B 652 REMARK 465 TYR B 653 REMARK 465 ASN B 659 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 461 OG REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 ARG A 470 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 LYS A 504 CG CD CE NZ REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 517 CG CD CE NZ REMARK 470 LYS A 542 CG CD CE NZ REMARK 470 GLU A 593 CG CD OE1 OE2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 LYS A 656 CG CD CE NZ REMARK 470 ASN A 659 CG OD1 ND2 REMARK 470 ARG A 661 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 GLU A 708 CG CD OE1 OE2 REMARK 470 LYS A 711 CG CD CE NZ REMARK 470 LEU A 712 CG CD1 CD2 REMARK 470 LYS A 714 CG CD CE NZ REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 LYS B 502 CG CD CE NZ REMARK 470 LYS B 504 CG CD CE NZ REMARK 470 LYS B 510 CG CD CE NZ REMARK 470 LYS B 540 CG CD CE NZ REMARK 470 ARG B 570 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 618 CG CD CE NZ REMARK 470 GLU B 633 CG CD OE1 OE2 REMARK 470 LEU B 644 CG CD1 CD2 REMARK 470 TYR B 654 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 655 CG CD CE NZ REMARK 470 LYS B 656 CG CD CE NZ REMARK 470 THR B 657 OG1 CG2 REMARK 470 ARG B 661 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 675 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 711 CG CD CE NZ REMARK 470 LYS B 714 CG CD CE NZ REMARK 470 SER B 762 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 491 98.81 -67.53 REMARK 500 PRO A 579 39.67 -75.57 REMARK 500 ARG A 622 -8.16 72.99 REMARK 500 ASP A 623 51.16 -152.01 REMARK 500 ASN A 724 77.44 -100.93 REMARK 500 GLN B 491 95.65 52.16 REMARK 500 PRO B 579 39.35 -74.97 REMARK 500 ARG B 622 -6.00 70.84 REMARK 500 ASP B 623 50.05 -151.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 66T A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 66T B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4RWI RELATED DB: PDB REMARK 900 RELATED ID: 4RWK RELATED DB: PDB REMARK 900 RELATED ID: 4RWL RELATED DB: PDB DBREF 4RWJ A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4RWJ B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4RWJ MET A 449 UNP P11362 EXPRESSION TAG SEQADV 4RWJ GLY A 450 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS A 451 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS A 452 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS A 453 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS A 454 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS A 455 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS A 456 UNP P11362 EXPRESSION TAG SEQADV 4RWJ MET A 457 UNP P11362 EXPRESSION TAG SEQADV 4RWJ ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4RWJ SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4RWJ MET B 449 UNP P11362 EXPRESSION TAG SEQADV 4RWJ GLY B 450 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS B 451 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS B 452 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS B 453 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS B 454 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS B 455 UNP P11362 EXPRESSION TAG SEQADV 4RWJ HIS B 456 UNP P11362 EXPRESSION TAG SEQADV 4RWJ MET B 457 UNP P11362 EXPRESSION TAG SEQADV 4RWJ ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4RWJ SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 317 MET GLY HIS HIS HIS HIS HIS HIS MET ALA GLY VAL SER SEQRES 2 A 317 GLU TYR GLU LEU PRO GLU ASP PRO ARG TRP GLU LEU PRO SEQRES 3 A 317 ARG ASP ARG LEU VAL LEU GLY LYS PRO LEU GLY GLU GLY SEQRES 4 A 317 ALA PHE GLY GLN VAL VAL LEU ALA GLU ALA ILE GLY LEU SEQRES 5 A 317 ASP LYS ASP LYS PRO ASN ARG VAL THR LYS VAL ALA VAL SEQRES 6 A 317 LYS MET LEU LYS SER ASP ALA THR GLU LYS ASP LEU SER SEQRES 7 A 317 ASP LEU ILE SER GLU MET GLU MET MET LYS MET ILE GLY SEQRES 8 A 317 LYS HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR SEQRES 9 A 317 GLN ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER SEQRES 10 A 317 LYS GLY ASN LEU ARG GLU TYR LEU GLN ALA ARG ARG PRO SEQRES 11 A 317 PRO GLY LEU GLU TYR SER TYR ASN PRO SER HIS ASN PRO SEQRES 12 A 317 GLU GLU GLN LEU SER SER LYS ASP LEU VAL SER CYS ALA SEQRES 13 A 317 TYR GLN VAL ALA ARG GLY MET GLU TYR LEU ALA SER LYS SEQRES 14 A 317 LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU SEQRES 15 A 317 VAL THR GLU ASP ASN VAL MET LYS ILE ALA ASP PHE GLY SEQRES 16 A 317 LEU ALA ARG ASP ILE HIS HIS ILE ASP TYR TYR LYS LYS SEQRES 17 A 317 THR THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO SEQRES 18 A 317 GLU ALA LEU PHE ASP ARG ILE TYR THR HIS GLN SER ASP SEQRES 19 A 317 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE PHE THR SEQRES 20 A 317 LEU GLY GLY SER PRO TYR PRO GLY VAL PRO VAL GLU GLU SEQRES 21 A 317 LEU PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS SEQRES 22 A 317 PRO SER ASN CYS THR ASN GLU LEU TYR MET MET MET ARG SEQRES 23 A 317 ASP CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE SEQRES 24 A 317 LYS GLN LEU VAL GLU ASP LEU ASP ARG ILE VAL ALA LEU SEQRES 25 A 317 THR SER ASN GLN GLU SEQRES 1 B 317 MET GLY HIS HIS HIS HIS HIS HIS MET ALA GLY VAL SER SEQRES 2 B 317 GLU TYR GLU LEU PRO GLU ASP PRO ARG TRP GLU LEU PRO SEQRES 3 B 317 ARG ASP ARG LEU VAL LEU GLY LYS PRO LEU GLY GLU GLY SEQRES 4 B 317 ALA PHE GLY GLN VAL VAL LEU ALA GLU ALA ILE GLY LEU SEQRES 5 B 317 ASP LYS ASP LYS PRO ASN ARG VAL THR LYS VAL ALA VAL SEQRES 6 B 317 LYS MET LEU LYS SER ASP ALA THR GLU LYS ASP LEU SER SEQRES 7 B 317 ASP LEU ILE SER GLU MET GLU MET MET LYS MET ILE GLY SEQRES 8 B 317 LYS HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR SEQRES 9 B 317 GLN ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER SEQRES 10 B 317 LYS GLY ASN LEU ARG GLU TYR LEU GLN ALA ARG ARG PRO SEQRES 11 B 317 PRO GLY LEU GLU TYR SER TYR ASN PRO SER HIS ASN PRO SEQRES 12 B 317 GLU GLU GLN LEU SER SER LYS ASP LEU VAL SER CYS ALA SEQRES 13 B 317 TYR GLN VAL ALA ARG GLY MET GLU TYR LEU ALA SER LYS SEQRES 14 B 317 LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU SEQRES 15 B 317 VAL THR GLU ASP ASN VAL MET LYS ILE ALA ASP PHE GLY SEQRES 16 B 317 LEU ALA ARG ASP ILE HIS HIS ILE ASP TYR TYR LYS LYS SEQRES 17 B 317 THR THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO SEQRES 18 B 317 GLU ALA LEU PHE ASP ARG ILE TYR THR HIS GLN SER ASP SEQRES 19 B 317 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE PHE THR SEQRES 20 B 317 LEU GLY GLY SER PRO TYR PRO GLY VAL PRO VAL GLU GLU SEQRES 21 B 317 LEU PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS SEQRES 22 B 317 PRO SER ASN CYS THR ASN GLU LEU TYR MET MET MET ARG SEQRES 23 B 317 ASP CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE SEQRES 24 B 317 LYS GLN LEU VAL GLU ASP LEU ASP ARG ILE VAL ALA LEU SEQRES 25 B 317 THR SER ASN GLN GLU HET 66T A 801 34 HET 66T B 801 34 HETNAM 66T N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4- HETNAM 2 66T [(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE FORMUL 3 66T 2(C26 H33 N5 O3) FORMUL 5 HOH *87(H2 O) HELIX 1 1 GLY A 459 TYR A 463 5 5 HELIX 2 2 PRO A 474 ASP A 476 5 3 HELIX 3 3 GLY A 485 ALA A 488 5 4 HELIX 4 4 THR A 521 GLY A 539 1 19 HELIX 5 5 ASN A 568 ALA A 575 1 8 HELIX 6 6 SER A 596 LYS A 617 1 22 HELIX 7 7 ALA A 625 ARG A 627 5 3 HELIX 8 8 LEU A 662 MET A 667 5 6 HELIX 9 9 ALA A 668 ASP A 674 1 7 HELIX 10 10 THR A 678 PHE A 694 1 17 HELIX 11 11 PRO A 705 GLU A 715 1 11 HELIX 12 12 THR A 726 TRP A 737 1 12 HELIX 13 13 VAL A 740 ARG A 744 5 5 HELIX 14 14 THR A 746 THR A 761 1 16 HELIX 15 15 GLY B 459 TYR B 463 5 5 HELIX 16 16 PRO B 474 ASP B 476 5 3 HELIX 17 17 THR B 521 GLY B 539 1 19 HELIX 18 18 ASN B 568 ALA B 575 1 8 HELIX 19 19 SER B 596 LYS B 617 1 22 HELIX 20 20 ALA B 625 ARG B 627 5 3 HELIX 21 21 LEU B 662 MET B 667 5 6 HELIX 22 22 ALA B 668 ASP B 674 1 7 HELIX 23 23 THR B 678 THR B 695 1 18 HELIX 24 24 PRO B 705 GLU B 715 1 11 HELIX 25 25 THR B 726 TRP B 737 1 12 HELIX 26 26 VAL B 740 ARG B 744 5 5 HELIX 27 27 THR B 746 THR B 761 1 16 SHEET 1 A 5 LEU A 478 LEU A 484 0 SHEET 2 A 5 VAL A 492 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 A 5 VAL A 508 LYS A 514 -1 O THR A 509 N ALA A 497 SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 C 5 LEU B 478 LEU B 484 0 SHEET 2 C 5 VAL B 492 ILE B 498 -1 O VAL B 492 N LEU B 484 SHEET 3 C 5 VAL B 508 LYS B 514 -1 O VAL B 511 N ALA B 495 SHEET 4 C 5 TYR B 558 VAL B 561 -1 O VAL B 561 N ALA B 512 SHEET 5 C 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CISPEP 1 GLY B 485 GLU B 486 0 -6.56 CISPEP 2 GLU B 486 GLY B 487 0 4.59 SITE 1 AC1 13 LEU A 484 GLY A 485 ALA A 512 LYS A 514 SITE 2 AC1 13 GLU A 531 VAL A 561 GLU A 562 ALA A 564 SITE 3 AC1 13 SER A 565 GLY A 567 GLU A 571 LEU A 630 SITE 4 AC1 13 ASP A 641 SITE 1 AC2 12 LEU B 484 ALA B 512 LYS B 514 GLU B 531 SITE 2 AC2 12 VAL B 561 GLU B 562 ALA B 564 SER B 565 SITE 3 AC2 12 GLY B 567 LEU B 630 ASP B 641 PHE B 642 CRYST1 211.674 50.148 66.850 90.00 107.41 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004724 0.000000 0.001481 0.00000 SCALE2 0.000000 0.019941 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015677 0.00000